Identification and Management of a Novel PRDM5 Gene Pathologic Variant in a Family With Brittle Cornea Syndrome

Bonnie A Sklar1, Phattrawan Pisuchpen2, Mor Bareket3

  • 1Department of Ophthalmology, Wills Eye Hospital, Philadelphia PA.

Cornea
|September 15, 2023
PubMed

Insights

A novel PRDM5 gene variant causes brittle cornea syndrome (BCS) in three siblings, leading to severe eye problems like corneal thinning and scarring. This discovery aids in understanding BCS and its challenging surgical management.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Brittle cornea syndrome (BCS) is a rare genetic disorder affecting the cornea.
  • Understanding the genetic basis of BCS is crucial for diagnosis and management.

Observation:

  • A nonconsanguineous Laotian family with three siblings diagnosed with BCS was studied.
  • Ophthalmic examinations revealed myopia, blue sclerae, thin corneas, and variable corneal scarring in all affected siblings.

Findings:

  • A novel homozygous PRDM5 gene variant (c.1117_1123delinsTTTAATGCTTACAAATGTTTG p.Asp373Phefs*57) was identified as the cause of BCS in this family.
  • Histopathology of a sibling who underwent corneal transplant showed severe corneal thinning, absence of Bowman layer, and Descemet membrane abnormalities.
  • No other pathogenic variants in PRDM5 or ZNF469 were found in the affected individuals.

Implications:

  • This novel PRDM5 variant is strongly associated with BCS, supporting its pathogenicity.
  • The findings highlight the genetic heterogeneity of BCS and the importance of PRDM5.
  • Surgical interventions for BCS are complex due to extreme tissue fragility.
Abstract